Telix's Illuccix® PSMA-PET Imaging Agent Approved in Germany

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Telix-Illuccix

More Like This

PR Newswire associated0

Telix's Illuccix PSMA-PET Imaging Agent Approved in France

PR Newswire associated0

Illuccix® Approved in the United Kingdom

PR Newswire associated0

Illuccix® Receives European Approval

PR Newswire associated0

Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America

PR Newswire associated0

Telix and Wiik Pharma Sign Distribution Agreement for Illuccix® in the Nordic Region

PR Newswire associated0

Telix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®

PR Newswire associated0

Telix Submits Biologics License Application (BLA) for TLX250-CDx (Zircaix™) for Imaging of Kidney Cancer

PR Newswire associated0

NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports